Get the Stockscreener App
4.59
10.87%
-0.56
After Hours:
4.56
-0.03
-0.65%
Evoke Pharma Inc stock is traded at $4.59, with a volume of 53,777.
It is down -10.87% in the last 24 hours and up +0.41% over the past month.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
See More
Previous Close:
$5.15
Open:
$5.1
24h Volume:
53,777
Relative Volume:
0.32
Market Cap:
$7.15M
Revenue:
$8.62M
Net Income/Loss:
$-6.15M
P/E Ratio:
-0.4161
EPS:
-11.03
Net Cash Flow:
$-5.32M
1W Performance:
-12.07%
1M Performance:
+0.41%
6M Performance:
+48.54%
1Y Performance:
-20.86%
1-Day Range:
$4.5001
$5.15
1-Week Range:
$4.5001
$5.23
52-Week Range:
$1.94
$9.88
Evoke Pharma Inc Stock (EVOK) Company Profile
Name
Evoke Pharma Inc
Sector
Phone
858-345-1494
Address
420 STEVENS AVENUE, SOLANA BEACH, CA
Compare EVOK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
4.59 | 8.03M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-22-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Mar-05-19 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-08-18 | Reiterated | B. Riley FBR, Inc. | Buy |
| Oct-19-17 | Resumed | FBR & Co. | Buy |
| Mar-16-17 | Reiterated | Rodman & Renshaw | Buy |
| Jan-30-17 | Upgrade | Laidlaw | Neutral → Buy |
| Jan-05-17 | Upgrade | Rodman & Renshaw | Neutral → Buy |
| Dec-23-16 | Reiterated | Rodman & Renshaw | Neutral |
| Jul-19-16 | Reiterated | FBR Capital | Outperform |
| Jul-19-16 | Downgrade | Noble Financial | Buy → Hold |
| Jul-18-16 | Downgrade | Rodman & Renshaw | Buy → Neutral |
| Mar-16-16 | Initiated | Northland Capital | Outperform |
| Mar-14-16 | Reiterated | Ascendiant Capital Markets | Buy |
| Feb-17-16 | Resumed | FBR Capital | Outperform |
| Dec-03-14 | Reiterated | MLV & Co | Buy |
| Nov-07-14 | Initiated | MLV & Co | Buy |
| Apr-22-14 | Initiated | Laidlaw | Buy |
| Nov-19-13 | Initiated | Aegis Capital | Buy |
View All
Evoke Pharma Inc Stock (EVOK) Latest News
Evoke Pharma Inc expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Using Bollinger Bands to evaluate Evoke Pharma Inc.Portfolio Value Summary & Stepwise Swing Trade Plans - newser.com
Top chart patterns to watch in Evoke Pharma Inc.2025 Top Decliners & Weekly Return Optimization Plans - newser.com
Will Evoke Pharma Inc. stock continue dividend increasesJuly 2025 Spike Watch & Daily Market Momentum Tracking - newser.com
How to read the order book for Evoke Pharma Inc.Weekly Trend Recap & Free Risk Controlled Daily Trade Plans - newser.com
Using economic indicators to assess Evoke Pharma Inc. potentialMarket Trend Summary & Smart Allocation Stock Tips - newser.com
Identifying reversal signals in Evoke Pharma Inc.July 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
How currency fluctuations impact Evoke Pharma Inc. stockWeekly Trend Summary & Expert Verified Stock Movement Alerts - newser.com
Price action breakdown for Evoke Pharma Inc.Fed Meeting & Fast Gain Stock Tips - newser.com
Quantitative breakdown of Evoke Pharma Inc. recent moveWeekly Trade Review & Free Fast Entry Momentum Trade Alerts - newser.com
Why Evoke Pharma Inc. stock is a value investor pickJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com
Will Evoke Pharma Inc. rebound enough to break evenJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
How sustainable is Evoke Pharma Inc. stock dividend payoutJuly 2025 Spike Watch & Daily Market Momentum Tracking - newser.com
Evaluating Evoke Pharma Inc. with trendline analysisJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Key metrics from Evoke Pharma Inc.’s quarterly dataDay Trade & Free Community Consensus Stock Picks - newser.com
Will Evoke Pharma Inc. stock go up soonJuly 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
What valuation multiples suggest for Evoke Pharma Inc. stock2025 Big Picture & Fast Gaining Stock Reports - newser.com
Advanced analytics toolkit walkthrough for Evoke Pharma Inc.2025 Performance Recap & Fast Entry High Yield Tips - newser.com
How Evoke Pharma Inc. stock responds to policy changesQuarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com
Analyzing Evoke Pharma Inc. with risk reward ratio chartsJuly 2025 Macro Moves & AI Forecasted Stock Moves - newser.com
Custom strategy builders for tracking Evoke Pharma Inc.Market Volume Report & Real-Time Chart Breakout Alerts - newser.com
Evoke Pharma Inc Stock (EVOK) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.35%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):